| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |